Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1806 1
1826 1
1843 1
1902 1
1904 1
1906 1
1913 1
1919 1
1924 1
1925 1
1937 2
1949 3
1950 1
1952 1
1953 1
1954 6
1955 3
1956 4
1957 7
1958 3
1959 6
1960 8
1961 12
1962 8
1963 12
1964 7
1965 5
1966 6
1967 9
1969 4
1970 7
1971 3
1972 2
1973 2
1974 11
1975 15
1976 8
1977 16
1978 16
1979 17
1980 17
1981 20
1982 37
1983 31
1984 26
1985 32
1986 31
1987 36
1988 31
1989 36
1990 38
1991 42
1992 53
1993 58
1994 61
1995 66
1996 64
1997 84
1998 76
1999 61
2000 77
2001 74
2002 66
2003 78
2004 96
2005 97
2006 90
2007 104
2008 105
2009 124
2010 166
2011 135
2012 141
2013 165
2014 183
2015 195
2016 182
2017 214
2018 202
2019 174
2020 217
2021 206
2022 180
2023 200
2024 153
2025 94

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,418 results

Results by year

Filters applied: . Clear all
Page 1
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
Baumgartner CK, Ebrahimi-Nik H, Iracheta-Vellve A, Hamel KM, Olander KE, Davis TGR, McGuire KA, Halvorsen GT, Avila OI, Patel CH, Kim SY, Kammula AV, Muscato AJ, Halliwill K, Geda P, Klinge KL, Xiong Z, Duggan R, Mu L, Yeary MD, Patti JC, Balon TM, Mathew R, Backus C, Kennedy DE, Chen A, Longenecker K, Klahn JT, Hrusch CL, Krishnan N, Hutchins CW, Dunning JP, Bulic M, Tiwari P, Colvin KJ, Chuong CL, Kohnle IC, Rees MG, Boghossian A, Ronan M, Roth JA, Wu MJ, Suermondt JSMT, Knudsen NH, Cheruiyot CK, Sen DR, Griffin GK, Golub TR, El-Bardeesy N, Decker JH, Yang Y, Guffroy M, Fossey S, Trusk P, Sun IM, Liu Y, Qiu W, Sun Q, Paddock MN, Farney EP, Matulenko MA, Beauregard C, Frost JM, Yates KB, Kym PR, Manguso RT. Baumgartner CK, et al. Among authors: davis tgr. Nature. 2023 Oct;622(7984):850-862. doi: 10.1038/s41586-023-06575-7. Epub 2023 Oct 4. Nature. 2023. PMID: 37794185 Free PMC article.
View from perimenopause.
Thomas L, Davis T, Millar L, Patrick K, Townsend E. Thomas L, et al. Among authors: davis t. Emerg Med J. 2024 Nov 21;41(12):773-774. doi: 10.1136/emermed-2024-214190. Emerg Med J. 2024. PMID: 39393840 No abstract available.
Consensus Guidelines on Interventional Therapies for Knee Pain (STEP Guidelines) from the American Society of Pain and Neuroscience.
Hunter CW, Deer TR, Jones MR, Chang Chien GC, D'Souza RS, Davis T, Eldon ER, Esposito MF, Goree JH, Hewan-Lowe L, Maloney JA, Mazzola AJ, Michels JS, Layno-Moses A, Patel S, Tari J, Weisbein JS, Goulding KA, Chhabra A, Hassebrock J, Wie C, Beall D, Sayed D, Strand N. Hunter CW, et al. Among authors: davis t. J Pain Res. 2022 Sep 8;15:2683-2745. doi: 10.2147/JPR.S370469. eCollection 2022. J Pain Res. 2022. PMID: 36132996 Free PMC article. Review.
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study.
Bergin SP, Chemaly RF, Dadwal SS, Hill JA, Lee YJ, Haidar G, Luk A, Drelick A, Chin-Hong PV, Benamu E, Khawaja F, Nanayakkara D, Papanicolaou GA, Small CB, Fung M, Barron MA, Davis T, McClain MT, Maziarz EK, Madut DB, Bedoya AD, Gilstrap DL, Todd JL, Barkauskas CE, Bigelow R, Leimberger JD, Tsalik EL, Wolf O, Mughar M, Hollemon D, Duttagupta R, Lupu DS, Bercovici S, Perkins BA, Blauwkamp TA, Fowler VG Jr, Holland TL. Bergin SP, et al. Among authors: davis t. Clin Infect Dis. 2024 Mar 20;78(3):775-784. doi: 10.1093/cid/ciad599. Clin Infect Dis. 2024. PMID: 37815489 Free PMC article.
Brain Targeting Nanomedicines: Pitfalls and Promise.
Kakinen A, Jiang Y, Davis TP, Teesalu T, Saarma M. Kakinen A, et al. Among authors: davis tp. Int J Nanomedicine. 2024 May 27;19:4857-4875. doi: 10.2147/IJN.S454553. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38828195 Free PMC article. Review.
Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint.
Tsao HW, Anderson S, Finn KJ, Perera JJ, Pass LF, Schneider EM, Jiang A, Fetterman R, Chuong CL, Kozuma K, Stickler MM, Creixell M, Klaeger S, Phulphagar KM, Rachimi S, Verzani EK, Olsson N, Dubrot J, Pech MF, Silkworth W, Lane-Reticker SK, Allen PM, Ibrahim K, Knudsen NH, Cheng AY, Long AH, Ebrahimi-Nik H, Kim SY, Du PP, Iracheta-Vellve A, Robitschek EJ, Suermondt JSMT, Davis TGR, Wolfe CH, Atluri T, Olander KE, Rush JS, Sundberg TB, McAllister FE, Abelin JG, Firestone A, Stokoe D, Carr SA, Harding FA, Yates KB, Manguso RT. Tsao HW, et al. Among authors: davis tgr. Immunity. 2024 Dec 10;57(12):2863-2878.e12. doi: 10.1016/j.immuni.2024.10.013. Epub 2024 Nov 18. Immunity. 2024. PMID: 39561763 Free article.
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.
Chu F, Cao J, Liu J, Yang H, Davis TJ, Kuang SQ, Cheng X, Zhang Z, Karri S, Vien LT, Bover L, Sun R, Vega F, Green M, Davis RE, Neelapu SS. Chu F, et al. Among authors: davis tj. J Immunother Cancer. 2023 Nov 24;11(11):e007515. doi: 10.1136/jitc-2023-007515. J Immunother Cancer. 2023. PMID: 38007239 Free PMC article.
4,418 results